Story Highlights
A complaint warning about the safety issues at the Sturgis plant was sent to OSHA in February 2021, much earlier than the officially known complaints. Will production at the Sturgis plant again shut down?
In the latest twist to the baby formula controversy at Abbott Laboratories (ABT), it has come to the fore that Abbott received warnings from a former employee about quality control issues at the baby-formula Sturgis plant much earlier than previously known, according to a report by the Wall Street Journal.
At the time of writing the article, shares of the U.S.-based multinational medical devices and health care company had dropped almost 18% following the news.
